Abstract

PurposeDespite the potential for adaptive optics scanning light ophthalmoscopy (AOSLO) to quantify retinal disease progression at the cellular level, there remain few longitudinal studies investigating changes in cone density as a measure of disease progression. Here, we undertook a prospective, longitudinal study to investigate the variability of cone density measurements in normal subjects during a 2-year period.MethodsFourteen eyes of nine subjects with no known ocular pathology were imaged both at a baseline and a 2-year follow-up visit by using confocal AOSLO at five retinal locations. Two-year affine-registered images were created to minimize the effects of intraframe distortions. Regions of interest were cropped from baseline, 2-year manually aligned, and 2-year affine-registered images. Cones were identified (graded masked) and cone density was extracted.ResultsMean baseline cone density (cones/mm2) was 87,300, 62,200, 45,500, 28,700, and 18,200 at 190, 350, 500, 900, and 1500 μm, respectively. The mean difference (± standard deviation [SD]) in cone density from baseline to 2-year affine-registered images was 1400 (1700), 100 (1800), 300 (800), 400 (800), and 1000 (2400) cones/mm2 at the same locations. The mean difference in cone density during the 2-year period was lower for affine-registered images than manually aligned images.ConclusionsThere was no meaningful change in normal cone density during a 2-year period. Intervisit variability in cone density measurements decreased when intraframe distortions between time points were minimized. This variability must be considered when planning prospective longitudinal clinical trials using changes in cone density as an outcome measure for assessing retinal disease progression.

Highlights

  • We undertook a prospective, longitudinal study to investigate the variability of cone density measurements in normal subjects during a 2-year period

  • There was no meaningful change in normal cone density during a 2-year period

  • With the ability to obtain images with cellular resolution in vivo, adaptive optics scanning light ophthalmoscopy (AOSLO) along with other adaptive optics ophthalmoscopy techniques has overcome two major limitations of histology: the ability to assess cell structure crosssectionally in patients before death, and the ability to follow up these same patients over time

Read more

Summary

Introduction

W. Morgan, Department of Ophthalmology, University of Pennsylvania, 3400 Civic Center Boulevard, 3rd Floor West, 3-112W Ophthalmology, Philadelphia, PA 19104, USA; jwmorgan@ pennmedicine.upenn.edu. Despite the potential for adaptive optics scanning light ophthalmoscopy (AOSLO) to quantify retinal disease progression at the cellular level, there remain few longitudinal studies investigating changes in cone density as a measure of disease progression. We undertook a prospective, longitudinal study to investigate the variability of cone density measurements in normal subjects during a 2-year period

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call